Alu in Lynch syndrome: A danger SINE?

Cancer Prevention Research

Volumn 4, Issue 10, 2011, Pages 1527-1530

  Hitchins, Megan P ^a   Burn, John ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; EPITHELIAL CELL ADHESION MOLECULE; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6;

ALU SEQUENCE; CANCER SUSCEPTIBILITY; CPG ISLAND; DNA METHYLATION; EXON; FRAMESHIFT MUTATION; GENE DELETION; GENE DOSAGE; GENE MAPPING; GENE REARRANGEMENT; GENETIC COUNSELING; GENETIC SCREENING; GERM LINE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN GENOME; INTRON; LOSS OF FUNCTION MUTATION; MICROSATELLITE INSTABILITY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SHORT INTERSPERSED REPEAT; SPAIN;

ALU ELEMENTS; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; FEMALE; GENE REARRANGEMENT; GERM-LINE MUTATION; HUMANS; MALE; MUTS HOMOLOG 2 PROTEIN; SEQUENCE DELETION;

EID: 80053927739     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0417     Document Type: Review

References (35)

1. Peltomaki P, Vasen H. Mutations associated with HNPCC predisposition- update of ICG-HNPCC/INSiGHT mutation database. Dis Markers 2004;20:269-76. (Pubitemid 40164099)
2. Nystrom-Lahti M, Kristo P, Nicolaides NC, Chang SY, Aaltonen LA, Moisio AL, et al. Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nat Med 1995;1:1203-6.
3. van der Klift H, Wijnen J, Wagner A, Verkuilen P, Tops C, Otway R, et al. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC). Genes Chromosomes Cancer 2005;44:123-38. (Pubitemid 41306641)
4. Charbonnier F, Olschwang S, Wang Q, Boisson C, Martin C, Buisine MP, et al. MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer. Cancer Res 2002;62:848-53. (Pubitemid 34126963)
5. Charbonnier F, Baert-Desurmont S, Liang P, Di Fiore F, Martin C, Frerot S, et al. The 5′ region of the MSH2 gene involved in hereditary non-polyposis colorectal cancer contains a high density of recombinogenic sequences. Hum Mutat 2005;26:255-61. (Pubitemid 41258185)
6. Taylor CF, Charlton RS, Burn J, Sheridan E, Taylor GR. Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA. Hum Mutat 2003;22:428-33. (Pubitemid 38009945)
7. Wijnen J, van der Klift H, Vasen H, Khan PM, Menko F, Tops C, et al. MSH2 genomic deletions are a frequent cause of HNPCC. Nat Genet 1998;20:326-8. (Pubitemid 28541626)
8. Apessos A, Mihalatos M, Danielidis I, Kallimanis G, Agnantis NJ, Triantafillidis JK, et al. hMSH2 is the most commonly mutated MMR gene in a cohort of Greek HNPCC patients. Br J Cancer 2005;92:396-404. (Pubitemid 40343158)
9. Kloor M, Sutter C, Wentzensen N, Cremer FW, Buckowitz A, Keller M, et al. A large MSH2 Alu insertion mutation causes HNPCC in a German kindred. Hum Genet 2004;115:432-8. (Pubitemid 39341718)
10. Yanaba K, Nakagawa H, Takeda Y, Koyama N, Sugano K. Muir-Torre syndrome caused by partial duplication of MSH2 gene by Alu-mediated nonhomologous recombination. Br J Dermatol 2008;158:150-6. (Pubitemid 350221892)
11. Morak M, Koehler U, Schackert HK, Steinke V, Royer-Pokora B, Schulmann K, et al. Biallelic MLH1 SNP cDNA expression or constitutional promoter methylation can hide genomic rearrangements causing Lynch syndrome. J Med Genet 2011;48:513-9.
12. Wang Y, Friedl W, Sengteller M, Jungck M, Filges I, Propping P, et al. A modified multiplex PCR assay for detection of large deletions in MSH2 and MLH1. Hum Mutat 2002;19:279-86. (Pubitemid 34195190)
13. Borras E, Pineda M, Blanco I, Jewett EM, Wang F, Teule A, et al. MLH1 founder mutations with moderate penetrance in Spanish Lynch syndrome families. Cancer Res 2010;70:7379-91.
14. Blokhuis MM, Goldberg PA, Pietersen GE, Algar U, Vorster AA, Govender D, et al. The extracolonic cancer spectrum in females with the common 'South African' hMLH1 c.C1528T mutation. Fam Cancer 2008;7:191-8.
15. Hitchins MP, Ward RL. Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer. J Med Genet 2009;46:793-802.
16. Chan TL, Yuen ST, Kong CK, Chan YW, Chan AS, Ng WF, et al. Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer. Nat Genet 2006;38:1178-83. (Pubitemid 44470364)
17. Ligtenberg MJ, Kuiper RP, Chan TL, Goossens M, Hebeda KM, Voorendt M, et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1. Nat Genet 2009;41:112-7.
18. Kempers MJ, Kuiper RP, Ockeloen CW, Chappuis PO, Hutter P, Rahner N, et al. Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncol 2011;12:49-55.
19. Lynch HT, Riegert-Johnson DL, Snyder C, Lynch JF, Hagenkord J, Boland CR, et al. Lynch syndrome-associated extracolonic tumors are rare in two extended families with the same EPCAM deletion. Am J Gastroenterol 2011 Jul 19. [Epub ahead of print].
20. Pérez-Cabornero L, Borras E, Infante M, Velasco EA, Acedo A, Lastra E, et al. Characterization of new founder Alu-mediated rearrangements in MSH2 gene associated with a Lynch syndrome phenotype. Cancer Prev Res 2011;4:1546-55.
21. Pérez-Cabornero L, Infante M, Velasco EA, Lastra E, Acedo A, Miner C, et al. Frequency of rearrangements in Lynch syndrome cases associated to MSH2. Characterization of a new deletion involving both EPCAM and the 5 prime part of MSH2. Cancer Prev Res 2011;4:1556-62.
22. Lucci-Cordisco E, Rovella V, Carrara S, Percesepe A, Pedroni M, Bellacosa A, et al. Mutations of the 'minor' mismatch repair gene MSH6 in typical and atypical hereditary nonpolyposis colorectal cancer. Fam Cancer 2001;1:93-9. (Pubitemid 35221522)
23. Jurka J. Evolutionary impact of human Alu repetitive elements. Curr Opin Genet Dev 2004;14:603-8. (Pubitemid 39505363)
24. Li L, McVety S, Younan R, Liang P, Du Sart D, Gordon PH, et al. Distinct patterns of germ-line deletions in MLH1 and MSH2: the implication of Alu repetitive element in the genetic etiology of Lynch syndrome (HNPCC). Hum Mutat 2006;27:388.
25. Viel A, Petronzelli F, Della Puppa L, Lucci-Cordisco E, Fornasarig M, Pucciarelli S, et al. Different molecular mechanisms underlie genomic deletions in the MLH1 Gene. Hum Mutat 2002;20:368-74. (Pubitemid 35285055)
26. Kuiper RP, Vissers LE, Venkatachalam R, Bodmer D, Hoenselaar E, Goossens M, et al. Recurrence and variability of germline EPCAM deletions in Lynch syndrome. Hum Mutat 2011;32:407-14.
27. Franke G, Bausch B, Hoffmann MM, Cybulla M, Wilhelm C, Kohlhase J, et al. Alu-Alu recombination underlies the vast majority of large VHL germline deletions: Molecular characterization and genotype-phenotype correlations in VHL patients. Hum Mutat 2009;30:776-86.
28. Wilson AS, Power BE, Molloy PL. DNA hypomethylation and human diseases. Biochim Biophys Acta 2007;1775:138-62.
29. Carbone L, Harris RA, Vessere GM, Mootnick AR, Humphray S, Rogers J, et al. Evolutionary breakpoints in the gibbon suggest association between cytosine methylation and karyotype evolution. PLoS Genet 2009;5:e1000538.
30. Bourc'his D, Bestor TH. Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L. Nature 2004;431:96-9. (Pubitemid 39215115)
31. Vincent JB, Paterson AD, Strong E, Petronis A, Kennedy JL. The unstable trinucleotide repeat story of major psychosis. Am J Med Genet 2000;97:77-97. (Pubitemid 30257330)
32. Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 2005;23:609-18. (Pubitemid 46224239)
33. Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003;349:247-57. (Pubitemid 36859476)
34. Xie J, Guillemette S, Peng M, Gilbert C, Buermeyer A, Cantor SB. An MLH1 mutation links BACH1/FANCJ to colon cancer, signaling, and insight toward directed therapy. Cancer Prev Res 2010;3:1409-16.
35. Burn J GA, Macrae F, Mecklin J-P, Moeslein G, Olschwang S, et al. The long term impact of aspirin on cancer risk in carriers of hereditary colorectal cancer: the CAPP2 randomised controlled trial. Lancet 2011;In press.